MedTrace Logo

Evaluation of Equivalent Minimum Alveolar Concentration (eMAC) During Propofol/Remifentanil Anesthesia

NCT05789992 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2023-06-15

No results posted yet for this study

Summary

The aim of this study is to verify the accuracy of eMAC compared to Bispectral Index (BIS) for depth and nociceptive stimulation monitoring of anesthesia during general anesthesia.

Conditions

  • General Anaesthesia

Interventions

DRUG

Propofol

Propofol (Random:3-5ug/ml)

DRUG

Low Remifentanil

Remifentanil (Random:0-3ug/ml)

DRUG

Heigh Remifentanil

Remifentanil (Random:3-5ug/ml)

PROCEDURE

Intubation

Endotracheal intubation before surgery

PROCEDURE

tetanic electrical stimulation

tetanic electrical stimulation before surgery

Sponsors & Collaborators

  • Zhang Haopeng

    lead OTHER

Principal Investigators

  • Haopeng Zhang, Dr · Xijing Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-03
Primary Completion
2023-04-29
Completion
2023-04-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05789992 on ClinicalTrials.gov